Viviabiotech
  • Services
    • Overview. What do we offer?
    • Ex vivo Assays for Hematologic Malignancies
      • Overview
      • Cytotoxicity Assay
      • Proliferation Assay
        • AML
        • CLL
        • MM
      • Differentiation Assay
      • CDC Assay
      • ADCC Assay
      • MRD + Cells Assay
      • ADCs
      • Bispecific Antibodies
      • Immuno Oncology Therapies
      • Cell Therapies
      • Targeted Therapies
      • Custom Assays
    • 3D Cultures Solid Tumor Assays
      • Overview
      • Cytotoxicity Assay
      • Bispecific Antibodies
      • Immuno Oncology Therapies
      • TILs Expansion
      • Custom Assays
    • Ex vivo Assays for Autoimmune Disease
      • Overview
      • B-Cell Assays
      • T-Cell Assays
    • Hematotoxicity
      • Overview
      • Selectivity & Hematotoxicity
      • ADCs Activity & Hematotoxicity Assay
    • Molecular Biology
      • Overview
      • Combined Functional and Molecular Studies
      • NGS methods
    • Bioinformatic Analysis
      • Overview
      • Compound Profiling by Flow Cytometry
      • Data Analysis for Molecular Biology Assays
      • Advanced Analysis and Visualization through TIBCO Spotfire
    • Access to Patient Samples
    • Biomarker Discovery and CDx
  • Our Value
    • Overview
    • Our Experience
    • Projects Management
    • Precision Medicine
      • Overview
      • PharmaFlow PM Test
      • Personalized Cancer Treatments
    • Regulatory Compliance
    • Our Team
  • Resources
    • Overview
    • Scientific Publications
    • Posters
    • Brochures
    • Blog
  • Contact Us
  • SEARCH
    • Log In
    • Register

Monthly Archives: March 2025

Home 2026 March
Multiple Myeloma Research: The Need For Functional Profiling In A Complex Therapeutic Landscape

Multiple Myeloma Research: The Need for Functional Profiling in a Complex Therapeutic Landscape

  • March 15, 2025
  • Sebastián Patriarca
  • Blog
Despite advances in multiple myeloma therapy, predicting patient response remains a major challenge. Vivia Biotech addresses this gap with functional ex vivo profiling in whole bone marrow, revealing drug efficacy and resistance in real time. Learn how this approach enhances precision medicine in a complex treatment landscape.
Read More→


Log In
  • Services
  • Ex vivo Assays for Hematologic Malignancies
  • 3D Cultures Solid Tumor Assays
  • Ex vivo Assays for Autoimmune Disease
  • Hematotoxicity
  • Molecular Biology
  • Bioinformatic Analysis
  • Access to Patient Samples
  • Biomarker Discovery and CDx
  • Our Value
  • Our Experience
  • Projects Management
  • Precision Medicine
  • Regulatory Compliance
  • Our Team
  • Resources
  • Scientific Publications
  • Posters
  • Brochures
  • Blog

Log In
Privacy Policy - Work With Us - Contact Us
2026 Vivia Biotech S.L. - All Rights Reserved
Reproduction of any materials from the website is forbidden without our permission